![[Image] Clinigen K.K. and GC Pharma announced an exclusive licensing agreement in Japan to commercialize Hunterase (Idursulfase-beta) ICV.](https://photos.prnasia.com/media_files/static/2019/04/thumbs/201904041136_1529388d_2.jpg)
| Caption | [Image] Clinigen K.K. and GC Pharma announced an exclusive licensing agreement in Japan to commercialize Hunterase (Idursulfase-beta) ICV. |
| Source | GC Pharma |
| Download | |
| Related Press Releases Links |
Clinigen K.K. and GC Pharma Announce Exclusive Licensing Agreement in Japan for Hunterase (Idursulfase-beta) ICV, Hunter Syndrome Drug Clinigen K.K.获亨特氏综合征治疗药Hunterase日本独家许可 |